1.265USD-4.17%Mkt Cap: 315.36M USDP/E: —Last update: 2026-06-01
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, developing cell replacement therapies to treat serious medical conditions in the United States and internationally. The company develops OpRegen, a…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap315.36M USD
Enterprise Value279.40M USD
Revenue (TTM)14.78M USD
Gross Profit14.41M USD
Net Income (TTM)-63.53M USD
Revenue/Share0.0630 USD
Last Price1.265 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees72
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-14.78
PEG10.64
EV/EBITDA-12.62
EV/Revenue18.91
P/S22.43
P/B6.16
EPS (TTM)-0.29
EPS (Forward)-0.09
52W Range
0.640043% of range2.090
52W High2.090 USD
52W Low0.6400 USD
Profitability
Gross Margin99.00%
Oper. Margin-440.17%
EBITDA Margin-149.83%
Profit Margin-436.47%
ROE-142.61%
ROA-56.43%
Growth
Revenue Growth14.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-18.92M USD
CapEx (TTM)522.00K USD
FCF Margin-98.97%
FCF Yield-4.64%
Net Debt-50.99M USD
Net Debt/EBITDA2.30
Balance Sheet
Debt/Equity0.05
Current Ratio6.89
Quick Ratio6.65
Book Value/Sh0.2160 USD
Cash/Share0.2140 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split3:1
Split DateOct 31, 1997
Analyst Consensus
Rating1.4 (Strong Buy)
Target (Mean)5.500 USD
Target Range3.000 USD – 9.000 USD
# Analysts6
Ownership
Shares Out.249.30M
Float187.28M
Insiders4.93%
Institutions47.53%
Short Interest
Short Ratio18.8d
Short % Float17.41%
Short % Out.10.40%
Shares Short25.92M
Short (prev mo.)25.29M
Technical
SMA 501.466 (-13.7%)
SMA 2001.591 (-20.5%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)1.24M
Avg Vol (10d)1.19M
Technical Indicators
RSI (14)43.8
MACD-0.0545
MACD Signal-0.0664
MACD Hist.+0.0120
BB Upper1.491 USD
BB Middle1.334 USD
BB Lower1.177 USD
BB Width23.54%
ATR (14)0.0804 USD
Vol Ratio (20d)0.34x